The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1167
ISSUE1167
October 13, 2003
Rosuvastatin - a New Lipid-lowering Drug
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Rosuvastatin - a New Lipid-lowering Drug
October 13, 2003 (Issue: 1167)
Rosuvastatin (Crestor - AstraZeneca), an HMG-CoA reductase inhibitor (or "statin"), was recently approved by the FDA for lowering serum cholesterol and triglyceride concentrations and raising HDL cholesterol levels. Rosuvastatin, like other statins,...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.